Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woosuk S Hur

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 22, 2026
Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic SequelaeWoosuk S Hur, Yesha N Patel, Sara R Abrahams, et al.
Blood|October 13, 2023
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisWoosuk S Hur, Tomohiro Kawano, Jean Marie N Mwiza, et al.
Blood|December 14, 2021
Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutationWoosuk S Hur, David S Paul, Emma G Bouck, et al.
Blood|December 27, 2021
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNALih Jiin Juang, Woosuk S Hur, Lakmali M Silva, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 22, 2026
Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic SequelaeWoosuk S Hur, Yesha N Patel, Sara R Abrahams, et al.
Blood|October 13, 2023
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisWoosuk S Hur, Tomohiro Kawano, Jean Marie N Mwiza, et al.
Blood|December 14, 2021
Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutationWoosuk S Hur, David S Paul, Emma G Bouck, et al.
Blood|December 27, 2021
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNALih Jiin Juang, Woosuk S Hur, Lakmali M Silva, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
Pageof 2